市場調査レポート

フランスの疾患発生率と有病率

France, Disease Incidence and Prevalence

発行 Medtech Insight 商品コード 247874
出版日 ページ情報 英文 236 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
フランスの疾患発生率と有病率 France, Disease Incidence and Prevalence
出版日: 2014年03月31日 ページ情報: 英文 236 Pages
概要

欧州における高齢人口の増加と平均寿命の伸びにより、主な病気/疾患の発生率と有病率は上昇し、欧州の医療産業に大きな影響を及ぼすと予測されています。

当レポートは、フランスにおける主な病気/疾患の発生率と有病率について調査し、その他の欧州諸国と比較しており、概略下記の構成でお届けいたします。

イントロダクション

第1章 血液障害

  • 貧血
  • 血友病

第2章 癌

  • 膀胱癌
  • 脳腫瘍
  • 乳癌
  • 子宮頸/子宮癌
  • 大腸/直腸癌
  • 食道癌
  • 腎臓/尿路上皮癌
  • 白血病
  • 肺癌
  • リンパ腫
  • メラノーマ(黒色腫)
  • 口腔癌
  • 卵巣癌
  • 膵臓癌
  • 前立腺癌
  • 胃癌
  • 精巣癌

第3章 心血管疾患

  • 心不整脈
  • 心不全
  • 心臓弁膜症
  • 高血圧症
  • 血管障害

第4章 代謝性疾患

  • 胆石症
  • 慢性腎疾患/末期腎疾患
  • 糖尿病
  • 尿石症

第5章 筋骨格疾患

  • 関節炎
  • 手根管症候群
  • 半月板および靭帯/腱損傷
  • 筋ジストロフィー
  • 骨粗しょう症

第6章 神経疾患・精神疾患

  • アルツハイマー病・認知症
  • 筋萎縮性側索硬化症
  • 双極性障害
  • 脳血管疾患
  • うつ病
  • てんかん
  • ハンチントン病
  • 水頭症
  • 多発性硬化症
  • 重症筋無力症
  • パーキンソン病
  • 統合失調症

第7章 眼科疾患

  • 白内障
  • 緑内障

第8章 生殖障害および泌尿生殖器障害

  • 良性前立腺過形成
  • 子宮内膜症
  • 勃起障害
  • 不妊
  • 尿失禁

第9章 呼吸器系疾患

  • 急性呼吸促迫症候群
  • α1-アンチトリプシン欠乏症と肺気腫
  • 無呼吸症
  • 喘息
  • 慢性閉塞性肺疾患
  • 嚢胞性線維症
  • 気胸
  • 呼吸不全
  • 拘束性肺疾患

第10章 創傷

  • 糖尿病性潰瘍
  • 褥瘡
  • 手術創傷
  • 外傷性創傷

第11章 感染性疾患

  • 慢性気管支炎
  • ヒト免疫不全ウイルス(HIV)/後天性免疫不全症候群(AIDS)
  • 肺炎
  • 感染性海綿状脳症(TSE)
  • 結核

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: A710

As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/disorders in France. Incidence and prevalence figures are for the year 2012, the most recent year for which data are available.

This report is the first in a series of five reports (Disease Incidence and Prevalence for France, Germany, Italy, Spain, and the United Kingdom) that examine the etiology and epidemiology of the most prevalent and costly diseases/disorders in Europe. Among the topics covered by each of these reports are Alzheimer's disease, anemia, arthritis, asthma, benign prostatic hyperplasia, bronchitis, burns/ traumatic wounds, cancer, depression, diabetes, emphysema, erectile dysfunction, glaucoma, heart failure, human immunodeficiency virus/acquired immune deficiency syndrome, hypertension, infertility, multiple sclerosis, osteoporosis, pneumonia, stroke, and transmissible spongiform encephalopathy.

In addition to proprietary data utilized from Medtech Insight's internal resources, many agencies and organizations have provided information including Alzheimer's Disease International, Association Française des Hémophiles (French Association of Hemophilia), Association France Parkinson, Bladder & Bowel Foundation, Cystic Fibrosis Europe, European Association of Urology, European Cancer Observatory, European Centre for Disease Prevention and Control, European Haemophilia Consortium, European Kidney Health Alliance, European Network for HIV/AIDS Surveillance, European Respiratory Society, European Society of Cardiology, European Tuberculosis Surveillance Network, Fédération Française des Groupements de Parkinsoniens (French Federation of Groups Parkinsonian), French Cystic Fibrosis Association, French Society for Research and Sleep Medicine, International Diabetes Federation, International Glaucoma Association, International Osteoporosis Foundation, Multiple Sclerosis International Federation, Myasthenia Gravis Association, The Schizophrenia Association, Sickle Cell Cure Foundation, World Endometriosis Research Foundation, World Federation of Hemophilia, and the World Health Organization, among others.

Table of Contents

INTRODUCTION

  • Exhibit I-1: France, Selected National Healthcare Statistics

1. BLOOD DISORDERS: ANEMIA AND HEMOPHILIA

  • 1.1 Anemia
    • 1.1.1 Iron Deficiency Anemia
      • 1.1.1.1 Etiology
      • 1.1.1.2 Epidemiology
    • 1.1.2 Sickle Cell Anemia
      • 1.1.2.1 Etiology
      • 1.1.2.2 Epidemiology
    • 1.1.3 Thalassemia
      • 1.1.3.1 Etiology
      • 1.1.3.2 Epidemiology
  • 1.2 Hemophilia
    • 1.2.1 Etiology
    • 1.2.2 Epidemiology
  • Exhibit 1-1: Europe, Estimated Prevalence of Anemia, by Age and Gender
  • Exhibit 1-2: Bleeding Disorders, Worldwide Prevalence, 1999-2011
  • Exhibit 1-3: France, Anemia and Hemophilia, Incidence and Prevalence

2. CANCER

  • 2.1 2.1 Bladder Cancer
    • 2.1.1 Etiology
    • 2.1.2 Epidemiology
  • 2.2 2.2 Brain Tumors
    • 2.2.1 Etiology
    • 2.2.2 Epidemiology
  • 2.3 Breast Cancer
    • 2.3.1 Etiology
    • 2.3.2 Epidemiology
  • 2.4 Cervical/Uterine Cancer
    • 2.4.1 Etiology
    • 2.4.2 Epidemiology
  • 2.5 Colorectal Cancer
    • 2.5.1 Etiology
    • 2.5.2 Epidemiology
  • 2.6 Esophageal Cancer
    • 2.6.1 Etiology
    • 2.6.2 Epidemiology
  • 2.7 Kidney/Urothelial Cancer
    • 2.7.1 Etiology
    • 2.7.2 Epidemiology
  • 2.8 Leukemia
    • 2.8.1 Etiology
    • 2.8.2 Epidemiology
  • 2.9 Lung Cancer
    • 2.9.1 Etiology
    • 2.9.2 Epidemiology
  • 2.10 Lymphoma
    • 2.10.1 Etiology
    • 2.10.2 Epidemiology
  • 2.11 Melanoma
    • 2.11.1 Etiology
    • 2.11.2 Epidemiology
  • 2.12 Oral Cancer
    • 2.12.1 Etiology
    • 2.12.2 Epidemiology
  • 2.13 Ovarian Cancer
    • 2.13.1 Etiology
    • 2.13.2 Epidemiology
  • 2.14 Pancreatic Cancer
    • 2.14.1 Etiology
    • 2.14.2 Epidemiology
  • 2.15 Prostate Cancer
    • 2.15.1 Etiology
    • 2.15.2 Epidemiology
  • 2.16 Stomach Cancer
    • 2.16.1 Etiology
    • 2.16.2 Epidemiology
  • 2.17 Testicular Cancer
    • 2.17.1 Etiology
    • 2.17.2 Epidemiology
  • Exhibit 2-1: France, Selected Cancers, Incidence and Mortality

3. CARDIOVASCULAR DISEASES/DISORDERS

  • 3.1 Cardiac Arrhythmia
    • 3.1.1 Etiology
    • 3.1.2 Epidemiology
  • 3.2 Heart Failure
    • 3.2.1 Etiology
    • 3.2.2 Epidemiology
  • 3.3 Heart Valve Disorders
    • 3.3.1 Etiology
    • 3.3.2 Epidemiology
  • 3.4 Hypertension
    • 3.4.1 Etiology
    • 3.4.2 Epidemiology
  • 3.5 3.5 Vascular Disorders
    • 3.5.1 Aneurysms
      • 3.5.1.1 Etiology
      • 3.5.1.2 Epidemiology
    • 3.5.2 Angina Pectoris
      • 3.5.2.1 Etiology
      • 3.5.2.2 Epidemiology
    • 3.5.3 Atherosclerosis
      • 3.5.3.1 Etiology
      • 3.5.3.2 Epidemiology
    • 3.5.4 Myocardial Infarction
      • 3.5.4.1 Etiology
      • 3.5.4.2 Epidemiology
    • 3.5.5 Peripheral Vascular Disease
      • 3.5.5.1 Etiology
      • 3.5.5.2 Epidemiology
  • Exhibit 3-1: Standard Angina Pectoris Classification
  • Exhibit 3-2: France, Hypercholesterolemia, Prevalence, by Gender and Selected Region
  • Exhibit 3-3: France, Selected Cardiovascular Diseases/Disorders, Incidence and Prevalence

4. METABOLIC DISEASES/DISORDERS

  • 4.1 Cholelithiasis
    • 4.1.1 Etiology
    • 4.1.2 Epidemiology
  • 4.2 Chronic Kidney Disease/End-Stage Renal Disease
    • 4.2.1 Etiology
    • 4.2.2 Epidemiology
  • 4.3 Diabetes
    • 4.3.1 Etiology
    • 4.3.2 Epidemiology
  • 4.4 Urolithiasis
    • 4.4.1 Etiology
    • 4.4.2 Epidemiology
  • Exhibit 4-1: France, Selected Metabolic Diseases/Disorders, Incidence and Prevalence

5. MUSCULOSKELETAL DISEASES/DISORDERS

  • 5.1 Arthritis
    • 5.1.1 Etiology
    • 5.1.2 Epidemiology
  • 5.2 Carpal Tunnel Syndrome
    • 5.2.1 Etiology
    • 5.2.2 Epidemiology
  • 5.3 Meniscal and Ligament/Tendon Injuries
    • 5.3.1 Etiology
    • 5.3.2 Epidemiology
  • 5.4 Muscular Dystrophy
    • 5.4.1 Etiology
    • 5.4.2 Epidemiology
  • 5.5 Osteoporosis
    • 5.5.1 Etiology
    • 5.5.2 Epidemiology
  • Exhibit 5-1: France, Selected Musculoskeletal Diseases/Disorders, Incidence and Prevalence

6. NEUROLOGIC AND PSYCHIATRIC DISEASES/DISORDERS

  • 6.1 Alzheimer's Disease and Dementia
    • 6.1.1 Etiology
    • 6.1.2 Epidemiology
  • 6.2 Amyotrophic Lateral Sclerosis
    • 6.2.1 Etiology
    • 6.2.2 Epidemiology
  • 6.3 Bipolar Disorder
    • 6.3.1 Etiology
    • 6.3.2 Epidemiology
  • 6.4 Cerebrovascular Disorders
    • 6.4.1 Arteriovenous Malformation
      • 6.4.1.1 Etiology
      • 6.4.1.2 Epidemiology
    • 6.4.2 Stroke
      • 6.4.2.1 Etiology
      • 6.4.2.2 Epidemiology
  • 6.5 Depression
    • 6.5.1 Etiology
    • 6.5.2 Epidemiology
  • 6.6 Epilepsy
    • 6.6.1 Etiology
    • 6.6.2 Epidemiology
  • 6.7 Huntington's Disease
    • 6.7.1 Etiology
    • 6.7.2 Epidemiology
  • 6.8 Hydrocephalus
    • 6.8.1 Etiology
    • 6.8.2 Epidemiology
  • 6.9 Multiple Sclerosis
    • 6.9.1 Etiology
    • 6.9.2 Epidemiology
  • 6.10 Myasthenia Gravis
    • 6.10.1 Etiology
    • 6.10.2 Epidemiology
  • 6.11 Parkinson's Disease
    • 6.11.1 Etiology
    • 6.11.2 Epidemiology
  • 6.12 Schizophrenia
    • 6.12.1 Etiology
    • 6.12.2 Epidemiology
  • Exhibit 6-1: Europe, Dementia, Incidence and Prevalence, by Age and Gender
  • Exhibit 6-2: Incidence of Epilepsy per 100,000 Population
  • Exhibit 6-3: France, Selected Neurologic and Psychiatric Diseases/Disorders, Incidence and Prevalence

7. OPHTHALMIC DISORDERS: CATARACTS AND GLAUCOMA

  • 7.1 Cataracts
    • 7.1.1 Etiology
    • 7.1.2 Epidemiology
  • 7.2 Glaucoma
    • 7.2.1 Etiology
    • 7.2.2 Epidemiology
  • Exhibit 7-1: France, Cataracts and Glaucoma, Incidence and Prevalence

8. REPRODUCTIVE AND GENITOURINARY DISORDERS

  • 8.1 8.1 Benign Prostatic Hyperplasia
    • 8.1.1 Etiology
    • 8.1.2 Epidemiology
  • 8.2 Endometriosis
    • 8.2.1 Etiology
    • 8.2.2 Epidemiology
  • 8.3 Erectile Dysfunction
    • 8.3.1 Etiology
    • 8.3.2 Epidemiology
  • 8.4 Infertility
    • 8.4.1 Etiology
    • 8.4.2 Epidemiology
  • 8.5 Urinary Incontinence
    • 8.5.1 Etiology
    • 8.5.2 Epidemiology
  • Exhibit 8-1: France, Selected Reproductive and Genitourinary Disorders, Incidence and Prevalence

9. RESPIRATORY DISEASES/DISORDERS

  • 9.1 Acute Respiratory Distress Syndrome
    • 9.1.1 Etiology
    • 9.1.2 Epidemiology
  • 9.2 Alpha-1 Antitrypsin Deficiency and Emphysema
    • 9.2.1 Etiology
    • 9.2.2 Epidemiology
  • 9.3 Apnea
    • 9.3.1 Etiology
    • 9.3.2 Epidemiology
  • 9.4 Asthma
    • 9.4.1 Etiology
    • 9.4.2 Epidemiology
  • 9.5 Cystic Fibrosis
    • 9.5.1 Etiology
    • 9.5.2 Epidemiology
  • 9.6 Pneumothorax
    • 9.6.1 Etiology
    • 9.6.2 Epidemiology
  • 9.7 Respiratory Failure
    • 9.7.1 Etiology
    • 9.7.2 Epidemiology
  • 9.8 Restrictive Lung Disease
    • 9.8.1 Etiology
    • 9.8.2 Epidemiology
  • Exhibit 9-1: France, Selected Respiratory Diseases/Disorders, Incidence and Prevalence

10. WOUNDS

  • 10.1 Diabetic Ulcers
    • 10.1.1 Etiology
    • 10.1.2 Epidemiology
  • 10.2 Pressure Ulcers
    • 10.2.1 Etiology
    • 10.2.2 Epidemiology
  • 10.3 Surgical Wounds
    • 10.3.1 Etiology
    • 10.3.2 Epidemiology
  • 10.4 Traumatic Wounds
    • 10.4.1 Burns
    • 10.4.2 Head Injuries, Lacerations, Contusions and Abrasions
  • Exhibit 10-1: Contributory Factors for the Development of Pressure Ulcers
  • Exhibit 10-2: France, Diabetic and Pressure Ulcers and Surgical Wounds, Incidence and Prevalence
  • Exhibit 10-3: Classification of Burns, by Mechanism of Injury
  • Exhibit 10-4: France, Burns and Acute Traumatic Injury, Incidence

11. INFECTIOUS DISEASES/DISORDERS

  • 11.1 Chronic Bronchitis
    • 11.1.1 Etiology
    • 11.1.2 Epidemiology
  • 11.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome
    • 11.2.1 Etiology
    • 11.2.2 Epidemiology
  • 11.3 Pneumonia
    • 11.3.1 Etiology
    • 11.3.2 Epidemiology
  • 11.4 Transmissible Spongiform Encephalopathies
    • 11.4.1 Etiology
    • 11.4.2 Epidemiology
  • 11.5 Tuberculosis
    • 11.5.1 Etiology
    • 11.5.2 Epidemiology
  • Exhibit 11-1: Acquired Immune Deficiency Syndrome, Indicator Diseases
  • Exhibit 11-2: France, Selected Infectious Diseases/Disorders, Incidence and Prevalence
Back to Top